HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Givaudan-Roure

This article was originally published in The Rose Sheet

Executive Summary

Givaudan-Roure: Constructing a $50 mil. fragrance manufacturing and distribution facility in Mount Olive, N.J. scheduled for completion by 2000. The largest, single capital investment in the fragrance supplier's history, the state-of-the-art facility will be constructed on approximately 14 acres and is designed to boost capacity by 50% to meet the firm's increased growth projections. The construction announcement comes on the heels of recent corporate appointments that appear to demonstrate parent company Roche's commitment to its fragrance business ("The Rose Sheet" Oct. 13, 1997, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005121

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel